Anna Eshoo: “Well, my time has expired. But I have to tell you if it was my business model, I would go with consumers because they…”

I've long been a champion for protecting vulnerable communities from the harms that come with new technologies.

The Republican majority's actions are inconsistent with their calls for bipartisan collaboration.

I find it hypocritical when I hear time and time and time again that plans are often blocked by PBMs from offering the lowest-priced generic.

The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.